Cargando…
Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer
BACKGROUND: Secreted Wnt signaling antagonists have recently been described as frequent targets of epigenetic inactivation in human tumor entities. Since gene silencing of certain Wnt antagonists was found to be correlated with adverse patient survival in cancer, we aimed at investigating a potentia...
Autores principales: | Veeck, Jürgen, Wild, Peter J, Fuchs, Thomas, Schüffler, Peter J, Hartmann, Arndt, Knüchel, Ruth, Dahl, Edgar |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717119/ https://www.ncbi.nlm.nih.gov/pubmed/19570204 http://dx.doi.org/10.1186/1471-2407-9-217 |
Ejemplares similares
-
Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours
por: Veeck, Jürgen, et al.
Publicado: (2008) -
Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening
por: Kloten, Vera, et al.
Publicado: (2013) -
An Eye on the Wnt Inhibitory Factor Wif1
por: Poggi, Lucia, et al.
Publicado: (2018) -
The negative regulators of Wnt pathway—DACH1, DKK1, and WIF1 are methylated in oral and oropharyngeal cancer and WIF1 methylation predicts shorter survival
por: Paluszczak, Jarosław, et al.
Publicado: (2014) -
Loss of Dickkopf 3 Promotes the Tumorigenesis of Basal Breast Cancer
por: Lorsy, Eva, et al.
Publicado: (2016)